Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

The Lancet Oncology

Volumn 11, Issue 2, 2010, Pages 136-146

  Ueda, Tetsuya ^a,c   Volinia, Stefano ^a,e   Okumura, Hiroshi ^a,b   Shimizu, Masayoshi ^f   Taccioli, Cristian ^a   Rossi, Simona ^e,f   Alder, Hansjuerg ^a   Liu, Chang gong ^a,f   Oue, Naohide ^g   Yasui, Wataru ^g   Yoshida, Kazuhiro ^h,i   Sasaki, Hiroki ^j   Nomura, Sachiyo ^c   Seto, Yasuyuki ^c   Kaminishi, Michio ^c,d   Calin, George A ^f   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Showa General Hospital   (Japan)

^e UNIVERSITY OF FERRARA   (Italy)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g HIROSHIMA UNIVERSITY   (Japan)

^h HIROSHIMA UNIVERSITY   (Japan)

ⁱ GIFU UNIVERSITY   (Japan)

^j NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

AGED; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 75249107416     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70343-2     Document Type: Article

References (42)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Hohenberger P., and Gretschel S. Gastric cancer. Lancet 362 (2003) 305-315
3. Yasui W., Yokozaki H., Fujimoto J., Naka K., Kuniyasu H., and Tahara E. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol 35 (2000) 111-115
4. Stock M., and Otto F. Gene deregulation in gastric cancer. Gene 360 (2005) 1-19
5. Li Q.-L., Ito K., Sakakura C., et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109 (2002) 113-124
6. Jinawath N., Furukawa Y., Hasegawa S., et al. Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene 23 (2004) 6830-6844
7. Lagos-Quintana M., Rauhut R., Lendeckel W., and Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 294 (2001) 853-858
8. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
9. Krek A., Grun D., Poy M.N., et al. Combinatorial microRNA target predictions. Nat Genet 37 (2005) 495-500
10. Ambros V. The functions of animal microRNAs. Nature 431 (2004) 350-355
11. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., and Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34 (2006) D140-D144
12. Bentwich I., Avniel A., Karov Y., et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37 (2005) 766-770
13. Liu C.G., Calin G.A., Volinia S., and Croce C.M. MicroRNA expression profiling using microarrays. Nat Protoc 3 (2008) 563-578
14. Iorio M.V., Ferracin M., Liu C.G., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65 (2005) 7065-7070
15. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103 (2006) 2257-2261
16. Gramantieri L., Ferracin M., Fornari F., et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67 (2007) 6092-6099
17. Esquela-Kerscher A., and Slack F.J. Oncomirs: microRNAs with a role in cancer. Nat Rev Cancer 6 (2006) 259-269
18. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 6 (2006) 857-866
19. Calin G.A., Ferracin M., Cimmino A., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353 (2005) 1793-1801
20. Yanaihara N., Caplen N., Bowman E., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 (2006) 189-198
21. Bloomston M., Frankel W.L., Petrocca F., et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297 (2007) 1901-1908
22. Schetter A.J., Leung S.Y., Sohn J.J., et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299 (2008) 425-436
23. Garzon R., Volinia S., Liu C.G., et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111 (2008) 3183-3189
24. Nicoloso M.S., Spizzo R., Shimizu M., Rossi S., and Calin G.A. MicroRNAs: the micro steering wheel of tumour metastases. Nat Rev Cancer 9 (2009) 293-302
25. Krützfeldt J., Rajewsky N., Braich R., et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438 (2005) 685-689
26. Elmén J., Lindow M., Schütz S., et al. LNA-mediated microRNA silencing in non-human primates. Nature 452 (2008) 896-899
27. Akinc A., Zumbuehl A., Goldberg M., et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol 26 (2008) 561-569
28. Tong A.W., and Nemunaitis J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?. Cancer Gene Ther 15 (2008) 341-355
29. National Cancer Institute, Biometric Research Branch. BRB-ArrayTools. http://linus.nci.nih.gov/BRB-ArrayTools.html (accessed Dec 1, 2009).
30. Zhang Z., Li Z., Gao C., et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88 (2008) 1358-1366
31. Petrocca F., Visone R., Onelli M.R., et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13 (2008) 272-286
32. Visone R., Pallante P., Vecchione A., et al. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26 (2007) 7590-7595
33. Fukaya M., Isohata N., Ohta H., et al. Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. Gastroenterology 131 (2006) 14-29
34. Shi X.B., Xue L., Yang J., et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci USA 104 (2007) 19983-19988
35. Le M.T., Teh C., Shyh-Chang N., et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev 23 (2009) 862-876
36. Lee J.W., Choi C.H., Choi J.J., et al. Altered microRNA expression in cervical carcinomas. Clin Cancer Res 14 (2008) 2535-2542
37. Kumar M.S., Erkeland S.J., Pester R.E., et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 105 (2008) 3903-3908
38. Esquela-Kerscher A., Trang P., Wiggins J.F., et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7 (2008) 759-764
39. Motoyama K., Inoue H., Nakamura Y., Uetake H., Sugihara K., and Mori M. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 14 (2008) 2334-2340
40. Flynt A.S., Li N., Thatcher E.J., Solnica-Krezel L., and Patton J.G. Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nat Genet 39 (2007) 259-263
41. Yang H., Kong W., He L., et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68 (2008) 425-433
42. Luo H., Zhang H., Zhang Z., et al. Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res 28 (2009) 82